Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials

Gampenrieder, S. P., Rinnerthaler, G., & Greil, R. (2013). Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future. Journal of Oncology, 2013(), 60-71. https://doi.org/10.1155/2013/732047
Ademuyiwa, F. O., Ellis, M. J., & Ma, C. X. (2013). Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer. Journal of Oncology, 2013(), 83-90. https://doi.org/10.1155/2013/219869
Gucalp, A., & Traina, T. A. (2011). Triple-Negative Breast Cancer: Adjuvant Therapeutic Options. Chemotherapy Research and Practice, 2011(), 104-116. https://doi.org/10.1155/2011/696208
Guiu, S., Reynier, M. A. M., Toure, M., & Coudert, B. (2013). Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy. Journal of Oncology, 2013(), 155-163. https://doi.org/10.1155/2013/854121
Rana, P., & Sridhar, S. S. (2012). Efficacy and Tolerability of Lapatinib in the Management of Breast Cancer. Breast Cancer: Basic and Clinical Research, (2012), 67-77. https://doi.org/10.4137/BCBCR.S6374